ArticleThe British journal of surgery2024

Recurrence-free survival as a surrogate endpoint for overall survival after neoadjuvant chemotherapy and surgery for oesophageal squamous cell carcinoma.

Jun Okui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.